Awareness and utilization of genetic testing for hereditary cancers in cancer survivors: a cross-sectional 2021 HINTS-SEER study
This study highlights cancer survivor populations that may require additional support around awareness of and use of germline genetic testing.
Authors
- Mindy C. DeRouen (ORCID: https://orcid.org/0000-0002-7198-7629)
- Robin C. Vanderpool (ORCID: https://orcid.org/0000-0001-9995-4485)
- Stephen Li (ORCID: https://orcid.org/0000-0003-4287-8172)
- Sarah H. Nash (ORCID: https://orcid.org/0000-0002-9038-6001)
- Erin L. Van Blarigan (ORCID: https://orcid.org/0000-0001-5079-3385)
- Kirithiga Ramalingam (ORCID: https://orcid.org/0000-0002-1774-6891)
- Salma Shariff‐Marco (ORCID: https://orcid.org/0000-0002-2541-3333)
- Meg McKinley (ORCID: https://orcid.org/0000-0003-1260-9764)
Institutions
- University of Iowa (US)
- University of California, San Francisco (US)
- National Cancer Institute (US)
Publication Details
- Journal
- Journal of Cancer Survivorship
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1007/s11764-025-01823-3
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- California Department of Public Health
- National Cancer Institute